Effects of NIK-247 on CO-induced impairment of passive avoidance in mice

Shigeru Yoshida, Toshitaka Nabeshima, Kaoru Kinbara, Tsutomu Kameyama

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The effect of NIK-247 on carbon monoxide (CO)-induced amnesia were investigated. A step-down type passive avoidance task with mice was used to compare the effects of NIK-247 with those of tacrine. Two types of CO-induced amnesia model, acute and delayed models, were used. The acute amnesia model was developed using mice exposed to CO before memory consolidation, just after training, and a retention test carried out 24 h after training. The delayed amnesia model was prepared 7 days after CO exposure even when the animals were exposed to CO 4 h after training, after memory has consolidated. NIK-247 administered post-training at 0.03-0.3 and 3 mg/kg or pre-retention test (24 h after training) at 0.3 and 10 mg/kg attenuated the acute amnesia. In addition, NIK-247 (0.03, 0.1, 1 and 10 mg/kg) and tacrine (0.03, 0.1 and 1 mg/kg) administered before the retention test (7 days after CO exposure) improved retrieval in the delayed amnesia model. Tacrine (0.01-0.3 and 3 mg/kg), administered post-training, attenuated the acute amnesia but pre-retention test administration did not. The dose-response curves for NIK-247 and tacrine were biphasic bell-shaped. These results indicated that NIK-247 has an improving effect on hypoxia-induced acute and delayed cognitive dysfunction, and suggest that NIK-247 has promise as a nootropic drug for therapy of memory deficits in patients with cerebrovascular-type dementing disorders.

Original languageEnglish
Pages (from-to)247-252
Number of pages6
JournalEuropean Journal of Pharmacology
Volume214
Issue number2-3
DOIs
Publication statusPublished - 22-04-1992
Externally publishedYes

Fingerprint

Amnesia
Carbon Monoxide
Tacrine
Nootropic Agents
Cerebrovascular Disorders
Memory Disorders
amiridine
Learning
Drug Therapy
Retention (Psychology)

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Yoshida, Shigeru ; Nabeshima, Toshitaka ; Kinbara, Kaoru ; Kameyama, Tsutomu. / Effects of NIK-247 on CO-induced impairment of passive avoidance in mice. In: European Journal of Pharmacology. 1992 ; Vol. 214, No. 2-3. pp. 247-252.
@article{831dacb203d64867a005d0a3de87b9d8,
title = "Effects of NIK-247 on CO-induced impairment of passive avoidance in mice",
abstract = "The effect of NIK-247 on carbon monoxide (CO)-induced amnesia were investigated. A step-down type passive avoidance task with mice was used to compare the effects of NIK-247 with those of tacrine. Two types of CO-induced amnesia model, acute and delayed models, were used. The acute amnesia model was developed using mice exposed to CO before memory consolidation, just after training, and a retention test carried out 24 h after training. The delayed amnesia model was prepared 7 days after CO exposure even when the animals were exposed to CO 4 h after training, after memory has consolidated. NIK-247 administered post-training at 0.03-0.3 and 3 mg/kg or pre-retention test (24 h after training) at 0.3 and 10 mg/kg attenuated the acute amnesia. In addition, NIK-247 (0.03, 0.1, 1 and 10 mg/kg) and tacrine (0.03, 0.1 and 1 mg/kg) administered before the retention test (7 days after CO exposure) improved retrieval in the delayed amnesia model. Tacrine (0.01-0.3 and 3 mg/kg), administered post-training, attenuated the acute amnesia but pre-retention test administration did not. The dose-response curves for NIK-247 and tacrine were biphasic bell-shaped. These results indicated that NIK-247 has an improving effect on hypoxia-induced acute and delayed cognitive dysfunction, and suggest that NIK-247 has promise as a nootropic drug for therapy of memory deficits in patients with cerebrovascular-type dementing disorders.",
author = "Shigeru Yoshida and Toshitaka Nabeshima and Kaoru Kinbara and Tsutomu Kameyama",
year = "1992",
month = "4",
day = "22",
doi = "10.1016/0014-2999(92)90125-N",
language = "English",
volume = "214",
pages = "247--252",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

Effects of NIK-247 on CO-induced impairment of passive avoidance in mice. / Yoshida, Shigeru; Nabeshima, Toshitaka; Kinbara, Kaoru; Kameyama, Tsutomu.

In: European Journal of Pharmacology, Vol. 214, No. 2-3, 22.04.1992, p. 247-252.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of NIK-247 on CO-induced impairment of passive avoidance in mice

AU - Yoshida, Shigeru

AU - Nabeshima, Toshitaka

AU - Kinbara, Kaoru

AU - Kameyama, Tsutomu

PY - 1992/4/22

Y1 - 1992/4/22

N2 - The effect of NIK-247 on carbon monoxide (CO)-induced amnesia were investigated. A step-down type passive avoidance task with mice was used to compare the effects of NIK-247 with those of tacrine. Two types of CO-induced amnesia model, acute and delayed models, were used. The acute amnesia model was developed using mice exposed to CO before memory consolidation, just after training, and a retention test carried out 24 h after training. The delayed amnesia model was prepared 7 days after CO exposure even when the animals were exposed to CO 4 h after training, after memory has consolidated. NIK-247 administered post-training at 0.03-0.3 and 3 mg/kg or pre-retention test (24 h after training) at 0.3 and 10 mg/kg attenuated the acute amnesia. In addition, NIK-247 (0.03, 0.1, 1 and 10 mg/kg) and tacrine (0.03, 0.1 and 1 mg/kg) administered before the retention test (7 days after CO exposure) improved retrieval in the delayed amnesia model. Tacrine (0.01-0.3 and 3 mg/kg), administered post-training, attenuated the acute amnesia but pre-retention test administration did not. The dose-response curves for NIK-247 and tacrine were biphasic bell-shaped. These results indicated that NIK-247 has an improving effect on hypoxia-induced acute and delayed cognitive dysfunction, and suggest that NIK-247 has promise as a nootropic drug for therapy of memory deficits in patients with cerebrovascular-type dementing disorders.

AB - The effect of NIK-247 on carbon monoxide (CO)-induced amnesia were investigated. A step-down type passive avoidance task with mice was used to compare the effects of NIK-247 with those of tacrine. Two types of CO-induced amnesia model, acute and delayed models, were used. The acute amnesia model was developed using mice exposed to CO before memory consolidation, just after training, and a retention test carried out 24 h after training. The delayed amnesia model was prepared 7 days after CO exposure even when the animals were exposed to CO 4 h after training, after memory has consolidated. NIK-247 administered post-training at 0.03-0.3 and 3 mg/kg or pre-retention test (24 h after training) at 0.3 and 10 mg/kg attenuated the acute amnesia. In addition, NIK-247 (0.03, 0.1, 1 and 10 mg/kg) and tacrine (0.03, 0.1 and 1 mg/kg) administered before the retention test (7 days after CO exposure) improved retrieval in the delayed amnesia model. Tacrine (0.01-0.3 and 3 mg/kg), administered post-training, attenuated the acute amnesia but pre-retention test administration did not. The dose-response curves for NIK-247 and tacrine were biphasic bell-shaped. These results indicated that NIK-247 has an improving effect on hypoxia-induced acute and delayed cognitive dysfunction, and suggest that NIK-247 has promise as a nootropic drug for therapy of memory deficits in patients with cerebrovascular-type dementing disorders.

UR - http://www.scopus.com/inward/record.url?scp=0026600776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026600776&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(92)90125-N

DO - 10.1016/0014-2999(92)90125-N

M3 - Article

VL - 214

SP - 247

EP - 252

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -